Hematopoietic-specific heterozygous loss of DNMT3A exacerbates colitis-associated colon cancer Journal Article


Authors: Feng, Y.; Yuan, Q.; Newsome, R. C.; Robinson, T.; Bowman, R. L.; Zuniga, A. N.; Hall, K. N.; Bernsten, C. M.; Shabashvili, D. E.; Krajcik, K. I.; Gunaratne, C.; Zaroogian, Z. J.; Venugopal, K.; Casellas Roman, H. L.; Levine, R. L.; Chatila, W. K.; Yaeger, R.; Riva, A.; Jobin, C.; Kopinke, D.; Avram, D.; Guryanova, O. A.
Article Title: Hematopoietic-specific heterozygous loss of DNMT3A exacerbates colitis-associated colon cancer
Abstract: Clonal hematopoiesis (CH) is defined as clonal expansion of mutant hematopoietic stem cells absent diagnosis of a hematologic malignancy. Presence of CH in solid tumor patients, including colon cancer, correlates with shorter survival. We hypothesized that bone marrow-derived cells with heterozygous loss-of-function mutations of DNMT3A, the most common genetic alteration in CH, contribute to the pathogenesis of colon cancer. In a mouse model that combines colitis-associated colon cancer (CAC) with experimental CH driven by Dnmt3a+/Δ, we found higher tumor penetrance and increased tumor burden compared with controls. Histopathological analysis revealed accentuated colonic epithelium injury, dysplasia, and adenocarcinoma formation. Transcriptome profiling of colon tumors identified enrichment of gene signatures associated with carcinogenesis, including angiogenesis. Treatment with the angiogenesis inhibitor axitinib eliminated the colon tumor-promoting effect of experimental CH driven by Dnmt3a haploinsufficiency and rebalanced hematopoiesis. This study provides conceptually novel insights into non-tumor-cell-autonomous effects of hematopoietic alterations on colon carcinogenesis and identifies potential therapeutic strategies. © 2023 Feng et al.
Keywords: genetics; mutation; mouse; animal; animals; mice; colonic neoplasms; carcinogenesis; colon tumor; heterozygosity loss; loss of heterozygosity; colitis-associated cancer; colitis-associated neoplasms; dnmt3a protein, mouse
Journal Title: Journal of Experimental Medicine
Volume: 220
Issue: 11
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 2023-11-06
Start Page: e20230011
Language: English
DOI: 10.1084/jem.20230011
PUBMED: 37615936
PROVIDER: scopus
PMCID: PMC10450614
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger
  2. Ross Levine
    775 Levine
  3. Robert L Bowman
    52 Bowman
  4. Walid Khaled Chatila
    102 Chatila